Based in Sweden, Inicure is a startup.
Inicure develops novel small molecule agonists targeting formyl peptide receptor-1 (FPR1) to treat infectious diseases and combat antibiotic-resistant bacterial infections such as UTIs and MRSA.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.